Editor

8394 POSTS
0 COMMENTS

Subcutaneous Opdivo Equally Efficient, Protected as IV for Superior ccRCC

Subcutaneous Opdivo confirmed comparable efficacy and security to IV Opdivo in beforehand handled superior or metastatic clear cell renal cell carcinoma.Amongst sufferers with...

First Affected person Handled in Trial of PHST001 for Superior Strong Tumors

The First sufferers has been dosed in a part 1 trial of PHST001, a novel macrophage checkpoint inhibitor for superior strong tumors.Pheast Therapeutics...

Spring Seems Totally different This Yr

Georgia Hurst is a fierce affected person advocate for these with Lynch syndrome. Atone for all of Georgia's blogs right here!For so long as I...

Medical Trial of NEO100 Recruiting Sufferers With Malignant Gliomas

A part 2a medical trial of NEO100-01, which goals to deal with malignant gliomas, is at the moment recruiting sufferers. Full enrollment is...

Editor

8394 POSTS
0 COMMENTS
spot_img